Hudson Bay Capital Management LP Deciphera Pharmaceuticals, Inc. Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$9.11 - $13.98 $501,049 - $768,900	-55,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $274,800 - $444,400	-40,000 Reduced 42.11%	55,000 $510,000
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $4.04 Million - $5.67 Million	-152,500 Reduced 61.62%	95,000 $3.23 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $572,775 - $839,125	17,500 Added 7.61%	247,500 $9.06 Million
Q1 2021 May 14, 2021	BUY	$40.39 - $56.73 $1.01 Million - $1.42 Million	25,000 Added 12.2%	230,000 $10.3 Million
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $258,850 - $330,900	5,000 Added 2.5%	205,000 $11.7 Million
Q3 2020 Nov 12, 2020	SELL	$43.8 - $58.16 $438,000 - $581,600	-10,000 Reduced 4.76%	200,000 $10.3 Million
Q2 2020 Aug 12, 2020	BUY	$37.05 - $65.03 $1.85 Million - $3.25 Million	50,000 Added 31.25%	210,000 $12.5 Million
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $840,750 - $1.74 Million	25,000 Added 18.52%	160,000 $6.59 Million
Q4 2019 Feb 12, 2020	SELL	$31.7 - $69.93 $4.12 Million - $9.09 Million	-130,000 Reduced 49.06%	135,000 $8.4 Million
Q3 2019 Nov 13, 2019	BUY	$19.95 - $38.85 $399,000 - $777,000	20,000 Added 8.16%	265,000 $8.99 Million
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $2.39 Million - $2.98 Million	113,705 Added 86.6%	245,000 $5.53 Million
Q1 2019 May 15, 2019	BUY	$20.65 - $29.55 $2.71 Million - $3.88 Million	131,295 New	131,295 $3.05 Million
Q2 2018 Aug 13, 2018	SELL	$20.06 - $44.95 $2.51 Million - $5.62 Million	-125,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$20.04 - $29.71 $1.9 Million - $2.82 Million	-95,000 Reduced 43.18%	125,000 $2.51 Million
Q4 2017 Feb 12, 2018	BUY	$16.54 - $24.2 $330,800 - $484,000	20,000 Added 10.0%	220,000 $4.99 Million
Q3 2017 Nov 13, 2017	BUY	$17.65 - $18.99 $3.53 Million - $3.8 Million	200,000	200,000 $3.8 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account